neulastahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: | ||
Meta Tags
| Title | Febrile Neutropenia Reduction | Neulasta® (pegfilgrastim) |
| Description | The #1 prescribed long-acting G-CSF for over 1 million Find information about Neulasta® (pegfilgrastim) Onpro®, a G-CSF used to reduce the risk of chemo-related infection. See Full Prescribing & Safety |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 34.212.77.168 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
neulastahcp.com Valuation
|
US$13,470,525
Last updated: 2023-05-11 18:40:43
neulastahcp.com has Semrush global rank of 785,738. neulastahcp.com has an estimated worth of US$ 13,470,525, based on its estimated Ads revenue. neulastahcp.com receives approximately 1,554,292 unique visitors each day. Its web server is located in United States, with IP address 34.212.77.168. According to SiteAdvisor, neulastahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$13,470,525 |
| Daily Ads Revenue | US$12,435 |
| Monthly Ads Revenue | US$373,030 |
| Yearly Ads Revenue | US$4,476,359 |
| Daily Unique Visitors | 103,620 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| neulastahcp.com. | A | 298 | IP: 34.212.77.168 |
| neulastahcp.com. | A | 298 | IP: 52.41.203.130 |
| neulastahcp.com. | NS | 86400 | NS Record: ns-1963.awsdns-53.co.uk. |
| neulastahcp.com. | NS | 86400 | NS Record: ns-561.awsdns-06.net. |
| neulastahcp.com. | NS | 86400 | NS Record: ns-93.awsdns-11.com. |
| neulastahcp.com. | NS | 86400 | NS Record: ns-1354.awsdns-41.org. |
| neulastahcp.com. | MX | 300 | MX Record: 3 amgen-com.mail.protection.outlook.com. |
| neulastahcp.com. | TXT | 300 | TXT Record: facebook-domain-verification=8js8zpqzxmwgofof1zfxjz5kalrk7v |
HtmlToTextCheckTime:2023-05-11 18:40:43
| Indication Neulasta ® (pegfilgrastim) is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. .. Read More Neulasta ® is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. Prescribing Information Instructions for Use On-body Injector Patient Instructions for Use Onpro ® Kit HCP Instructions for Use Prefilled Syringe Instructions for Use Important Safety Information Indication Indication Indication Visit Patient Site Risk of Febrile Neutropenia Frequency of FN Hospitalizations Reducing FN Risk with Neulasta® Overcoming Next-day Delivery Challenges Real-world Evidence Real-world Evidence Studies Neulasta® Onpro® vs Other FN-Prophylaxis Options Keeping Patients’ Treatment Plans on Track Reliability and Innovation Reliable Supply |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 11 Nov 2021 08:47:43 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 147 Connection: keep-alive Set-Cookie: AWSALB=OUYtxRxKejRcEgrFJ0pOHBLXgGbjAnMwMJBHLcsxMVmDtV4AY2x+BurldbGNlvXOCYlCnQAICGg4LgHRXzqRsF/PRdGVyK9POUOxiYZWQYnqE6nLc7TZMoczshoS; Expires=Thu, 18 Nov 2021 08:47:43 GMT; Path=/ Set-Cookie: AWSALBCORS=OUYtxRxKejRcEgrFJ0pOHBLXgGbjAnMwMJBHLcsxMVmDtV4AY2x+BurldbGNlvXOCYlCnQAICGg4LgHRXzqRsF/PRdGVyK9POUOxiYZWQYnqE6nLc7TZMoczshoS; Expires=Thu, 18 Nov 2021 08:47:43 GMT; Path=/; SameSite=None Location: https://neulastahcp.com/ Strict-Transport-Security: max-age=31536000 Content-Security-Policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/ X-Frame-Options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com X-Xss-Protection: 1; mode=block HTTP/2 301 date: Thu, 11 Nov 2021 08:47:43 GMT content-type: text/html; charset=UTF-8 content-length: 151 location: https://www.neulastahcp.com/ set-cookie: AWSALB=MgJIRVPiFd7HH2V4yf3wHm2xm/YWHfDq69QKgeOpewJ2WuU1EG8E0MjjH/aQdIc2PJIQoPyPp4VazTHTNpWMkWn6LVjvxggxEkd36xG9e6hdDTaCnPWllhyHRxzO; Expires=Thu, 18 Nov 2021 08:47:43 GMT; Path=/ set-cookie: AWSALBCORS=MgJIRVPiFd7HH2V4yf3wHm2xm/YWHfDq69QKgeOpewJ2WuU1EG8E0MjjH/aQdIc2PJIQoPyPp4VazTHTNpWMkWn6LVjvxggxEkd36xG9e6hdDTaCnPWllhyHRxzO; Expires=Thu, 18 Nov 2021 08:47:43 GMT; Path=/; SameSite=None; Secure strict-transport-security: max-age=31536000 content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/ x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block HTTP/2 200 date: Thu, 11 Nov 2021 08:47:44 GMT content-type: text/html; charset=utf-8 content-length: 74016 set-cookie: AWSALB=YhCPJ0KJeZUWwmCe1inSXl0yyA40saHvU8Z7M2ELOSJnREBSOrn0BEBtEU7Rg2XG4yTmVF2oH0lKFyKJXGCA4DVVSE7a/GJa7Uqtdg9gi1P46iLqalk0s+pCXUnG; Expires=Thu, 18 Nov 2021 08:47:44 GMT; Path=/ set-cookie: AWSALBCORS=YhCPJ0KJeZUWwmCe1inSXl0yyA40saHvU8Z7M2ELOSJnREBSOrn0BEBtEU7Rg2XG4yTmVF2oH0lKFyKJXGCA4DVVSE7a/GJa7Uqtdg9gi1P46iLqalk0s+pCXUnG; Expires=Thu, 18 Nov 2021 08:47:44 GMT; Path=/; SameSite=None; Secure cache-control: private strict-transport-security: max-age=31536000 content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/ x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block |
neulastahcp.com Whois Information
Domain Name: NEULASTAHCP.COM Registry Domain ID: 1555601283_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-11T09:09:32Z Creation Date: 2009-05-13T23:06:51Z Registry Expiry Date: 2023-05-13T23:06:51Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1354.AWSDNS-41.ORG Name Server: NS-1963.AWSDNS-53.CO.UK Name Server: NS-561.AWSDNS-06.NET Name Server: NS-93.AWSDNS-11.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-11T07:52:21Z <<< |